Patents Assigned to XI' AN BIOCARE PHARMA LTD.
  • Publication number: 20230054001
    Abstract: The present invention provides a salt of a bile acid derivative, a crystal form thereof, a preparation method therefor and use thereof. The salt of a bile acid derivative, the crystal form thereof and a composition thereof provided by the present invention can improve cholestasis, reduce portal pressure, and improve liver function, and can be used for preparing medicaments for treating or alleviating chronic liver diseases, metabolic diseases, portal hypertension and related diseases.
    Type: Application
    Filed: April 7, 2021
    Publication date: February 23, 2023
    Applicant: XI'AN BIOCARE PHARMA LTD.
    Inventor: Guoqin FU
  • Patent number: 11028111
    Abstract: Provided are a compound for treating metabolic diseases having the structure as shown in formula (I) or formula (II), or a racemate, stereoisomer, geometric isomer, tautomer, solvate, hydrate, metabolite, pharmaceutically acceptable salt or prodrug thereof. The compound is an activator of FXR and/or a TGR5 receptor, and thus has the activity of activating FXR and/or a TGR5 receptor, and can be used in the preparation of drugs for treating chronic liver diseases, metabolic diseases or portal hypertension.
    Type: Grant
    Filed: August 15, 2018
    Date of Patent: June 8, 2021
    Assignee: XI' AN BIOCARE PHARMA LTD.
    Inventors: Guoqin Fu, Wei Ding, Bo Yin, Chao Yang, Cuiqin Wang, Yong Dou, Ruiling Wang